PROCEPT BioRobotics Corporation (BMV:PRCT)

Market Cap	19.08B -49.8%
Revenue (ttm)	5.89B +22.7%
Net Income	-1.92B
EPS	-34.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	948
Open	356.00
Previous Close	358.45
Day's Range	356.00 - 357.00
52-Week Range	356.00 - 653.92
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 3, 2026

About PROCEPT BioRobotics

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hype...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2007
• Employees: 888
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PRCT

Financial Performance

In 2025, PROCEPT BioRobotics's revenue was $308.05 million, an increase of 37.22% compared to the previous year's $224.50 million. Losses were -$95.57 million, 4.55% more than in 2024.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 20, 2026

Data Sources Report a data error